All patients underwent standardized evaluation. CT, MRI, positron emission tomography (PET)/CT and bone scan were employed to evaluate the efficacy and progression. An assessment was given every two cycles of systemic therapy, and every three months during the first three years of follow‐up. Efficacy was evaluated as complete response (CR), partial response (PR), stable disease (SD) or progressive disease (PD).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.